Onyia Jude
Officer at NBIX
- Sold, on record
- $16.2M
- Dollars the filings state
- Form 4 sales
- 14
- Latest Jun 1, 2026
- Form 144 notices
- 11
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- NBIXNEUROCRINE BIOSCIENCES INCOfficer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale NBIXRoutineFeb 13, 2025 2025
Sold 2,879 shares at $116.79 ($336k)
Onyia Jude, Chief Scientific Officer
10b5-1 planSold 13.7% of holdings ($2.4M position)18,089 shares left1.5x usual sizeFollows a Form 144Filing
- 2 Form 144 notice NBIXNoticeJul 2, 2025 +139 days
Filed to sell 80,181 shares ($10.3M)
Onyia Jude, Officer
10b5-1 plan34.4x usual sizeFiling
- 3 Form 4 sale NBIXUnusualJul 2, 2025 same day
Sold 20,362 shares at $130.13 ($2.6M)
Onyia Jude, Chief Scientific Officer
10b5-1 planSold 52.7% of holdings ($5M position)18,289 shares left8.7x usual sizeFollows a Form 144Filing
- 4 Form 4 sale NBIXUnusualJul 9, 2025 +7 days
Sold 59,819 shares at $130.46 ($7.8M)
Onyia Jude, Chief Scientific Officer
10b5-1 planSold 76.6% of holdings ($10.2M position)18,289 shares left25.7x usual sizeFollows a Form 144Filing
- 5 Form 144 notice NBIXNoticeMay 27, 2026 +322 days
Filed to sell 11,000 shares ($1.7M)
Onyia Jude, Officer
10b5-1 plan3.8x usual sizeFiling
- 6 Form 4 sale NBIXUnusualMay 27, 2026 same day
Sold 11,000 shares at $155.53 ($1.7M)
Onyia Jude, Chief Scientific Officer
10b5-1 planSold 29.9% of holdings ($5.7M position)25,846 shares left3.8x usual sizeFollows a Form 144Filing
- 7 Form 144 notice NBIXNoticeJun 1, 2026 +5 days
Filed to sell 11,000 shares ($1.7M)
Onyia Jude, Officer
10b5-1 plan1.6x usual sizeFiling
- 8 Form 4 sale NBIXRoutineJun 1, 2026 same day
Sold 11,000 shares at $160.25 ($1.8M)
Onyia Jude, Chief Scientific Officer
10b5-1 planSold 29.9% of holdings ($5.9M position)25,846 shares left1.6x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (25)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Jun 2, 2026 | NBIX | Chief Scientific Officer | Form 4 sale | 11,000 | $1.8M | 29.9% | Routine | SEC |
| Jun 1, 2026 | Jun 1, 2026 | NBIX | Officer | Form 144 notice | 11,000 | $1.7M | Notice | SEC | |
| May 27, 2026 | May 29, 2026 | NBIX | Chief Scientific Officer | Form 4 sale | 11,000 | $1.7M | 29.9% | Unusual | SEC |
| May 27, 2026 | May 27, 2026 | NBIX | Officer | Form 144 notice | 11,000 | $1.7M | Notice | SEC | |
| Jul 9, 2025 | Jul 11, 2025 | NBIX | Chief Scientific Officer | Form 4 sale | 59,819 | $7.8M | 76.6% | Unusual | SEC |
| Jul 2, 2025 | Jul 7, 2025 | NBIX | Chief Scientific Officer | Form 4 sale | 20,362 | $2.6M | 52.7% | Unusual | SEC |
| Jul 2, 2025 | Jul 2, 2025 | NBIX | Officer | Form 144 notice | 80,181 | $10.3M | Notice | SEC | |
| Feb 13, 2025 | Feb 14, 2025 | NBIX | Chief Scientific Officer | Form 4 sale | 2,879 | $336k | 13.7% | Routine | SEC |
| Feb 13, 2025 | Feb 13, 2025 | NBIX | Officer | Form 144 notice | 1,447 | $170k | Notice | SEC | |
| Feb 13, 2025 | Feb 13, 2025 | NBIX | Officer | Form 144 notice | 1,432 | $168k | Notice | SEC | |
| Jan 31, 2025 | Feb 4, 2025 | NBIX | Chief Scientific Officer | Form 4 sale | 126 | $19k | 0.8% | Routine | SEC |
| Jan 31, 2025 | Jan 31, 2025 | NBIX | Officer | Form 144 notice | 126 | $19k | Notice | SEC | |
| Nov 29, 2024 | Dec 3, 2024 | NBIX | Chief Scientific Officer | Form 4 sale | 2,331 | $294k | 13.1% | Routine | SEC |
| Nov 29, 2024 | Nov 29, 2024 | NBIX | Officer | Form 144 notice | 2,331 | $295k | Notice | SEC | |
| Feb 13, 2024 | Feb 15, 2024 | NBIX | Chief Scientific Officer | Form 4 sale | 1,432 | $190k | 9.8% | Routine | SEC |
| Feb 13, 2024 | Feb 13, 2024 | NBIX | Officer | Form 144 notice | 1,432 | $187k | Notice | SEC | |
| Jan 31, 2024 | Feb 2, 2024 | NBIX | Chief Scientific Officer | Form 4 sale | 126 | $18k | 1.1% | Routine | SEC |
| Jan 31, 2024 | Jan 31, 2024 | NBIX | Officer | Form 144 notice | 126 | $18k | Notice | SEC | |
| Nov 29, 2023 | Dec 1, 2023 | NBIX | Chief Scientific Officer | Form 4 sale | 2,331 | $265k | 16.6% | Routine | SEC |
| Nov 29, 2023 | Nov 29, 2023 | NBIX | Officer | Form 144 notice | 2,331 | $263k | Notice | SEC | |
| Aug 22, 2023 | Aug 22, 2023 | NBIX | Officer | Form 144 notice | 3,198 | $346k | Notice | SEC | |
| Aug 21, 2023 | Aug 23, 2023 | NBIX | Chief Scientific Officer | Form 4 sale | 3,198 | $343k | 24.9% | Routine | SEC |
| Feb 7, 2023 | Feb 8, 2023 | NBIX | Chief Scientific Officer | Form 4 sale | 4,508 | $461k | 40.9% | Unusual | SEC |
| Jan 31, 2023 | Feb 2, 2023 | NBIX | Chief Scientific Officer | Form 4 sale | 126 | $14k | 4.8% | Plan not stated | SEC |
| Nov 29, 2022 | Dec 1, 2022 | NBIX | Chief Scientific Officer | Form 4 sale | 2,331 | $284k | 49.6% | Unusual | SEC |